ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Afinitor Approved for Rare Disorder

November 5, 2010

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

Regulatory Agencies: Health Warnings Sought on Cigars

July 23, 1999

Hammond Resigns As Director Of USC Comp Center

May 29, 1981

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

Former NCAB chairman, President’s Cancer Panel member Paul Calabresi dead at 73.

October 31, 2003